Synopsys (NASDAQ:SNPS – Get Free Report) had its price target reduced by equities research analysts at Wells Fargo & Company from $535.00 to $450.00 in a report released on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the semiconductor company’s stock. Wells Fargo & Company‘s price target indicates a potential upside of 9.31% from the company’s previous close.
A number of other equities analysts have also recently weighed in on the company. Morgan Stanley raised their price objective on Synopsys from $480.00 to $525.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th. Needham & Company LLC restated a “buy” rating and issued a $580.00 price objective on shares of Synopsys in a report on Thursday, May 28th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. Robert W. Baird set a $558.00 target price on shares of Synopsys in a research report on Thursday, May 28th. Finally, Zacks Research upgraded shares of Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of “Moderate Buy” and an average price target of $565.06.
Get Our Latest Stock Report on Synopsys
Synopsys Trading Down 1.0%
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The business’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts expect that Synopsys will post 10.65 earnings per share for the current fiscal year.
Insider Activity
In other news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares in the company, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.56% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in SNPS. Sankala Group LLC purchased a new stake in Synopsys in the fourth quarter worth $25,000. Elevation Wealth Partners LLC lifted its position in Synopsys by 96.4% during the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 27 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in Synopsys during the fourth quarter valued at $28,000. IMG Wealth Management Inc. bought a new stake in shares of Synopsys during the 2nd quarter valued at $28,000. Finally, Atlas Capital Advisors Inc. bought a new stake in shares of Synopsys during the 4th quarter valued at $32,000. Institutional investors own 85.47% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories
- Five stocks we like better than Synopsys
- 3 Companies That Could Thrive While the Fed Holds Rates Steady
- Caterpillar’s Blowout Quarter May Point to More Industrial Winners
- Jeff Bezos’ Amazon Sale Looks Less Alarming Than the Headline Suggests
- 3 Overlooked Stocks Analysts Still Like as AI Trades Get Crowded
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
